Every year, thousands of new materials are created, yet many never reach their full potential because their applications aren’t immediately obvious – a challenge University of Toronto researchers aim ...

Obefazimod’s strong Phase 3 induction data positions Abivax as leading UC contender with novel mechanism and favorable safety ...